Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination
European Journal of Neurology · 2024-04 · 31 (4)
DOI: 10.1111/ene.16191 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 02.01.2024. Verfasst von Andrea Pilotto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, Department of Continuity of Care and Frailty, ASST Spedali Civili Brescia Hospital, Brescia, Italy. Hauptthemen laut MEDLINE: COVID-19, Conversion Disorder. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background and purpose The purpose of this study was to evaluate the possible correlation between SARS‐CoV‐2 vaccines and the onset of neurological syndromes. The aim was to challenge the association between SARS‐CoV‐2 vaccinations and the onset of acute functional neurological disorders (FNDs) compared to other neurological syndromes in hospitalized patients.
Methods
In this prospective cohort study, all adult inpatients consecutively admitted to a tertiary neurological centre were included. The prevalence and characteristics of neurological syndromes were compared between unvaccinated and vaccinated cases stratified according to the onset from vaccination. The study involved 843 subjects, namely 411 unvaccinated (UVC) and 432 vaccinated cases; these groups were comparable for demographics and clinical diagnosis distribution.
Results
Compared to UVC, subjects hospitalized within the first 30 days from vaccine exhibited higher prevalence of FNDs (12.3% vs. 3.6%; odds ratio 4.2, 95% confidence interval 1.6–11.1) and headache (10.8% vs. 5%; odds ratio 4.1, 95% confidence interval 1.9–8.8) but no other neurological syndromes. The FND cases following vaccinations showed similar premorbid conditions and severity but a higher percentage of sensory symptoms and pain compared to UVC FND cases.
Conclusions
SARS‐CoV‐2 vaccination is associated with a significant short‐term increased risk of FND and headache requiring hospitalization in an acute neurological setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurology Unit, Department of Continuity of Care and Frailty, ASST Spedali Civili Brescia Hospital, Brescia, Italy.
- Laboratory of Digital Neurology and Biosensors, University of Brescia, Brescia, Italy.
- Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
- Stroke Unit, ASST Spedali Civili of Brescia, Brescia, Italy.
- Brain Health Center, University of Brescia, Brescia, Italy.
ORCID-Profile: Andrea Pilotto
Zitieren
APA
Pilotto, A., Catania, M., Mattioli, I., Zoppi, N., Ceccardi, G., Rao, R., Gipponi, S., Magoni, M., Gamba, M., & Padovani, A. (2024). Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination. European Journal of Neurology, 31(4). https://doi.org/10.1111/ene.16191
Vancouver
Pilotto A, Catania M, Mattioli I, Zoppi N, Ceccardi G, Rao R, et al. Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination. European Journal of Neurology. 2024;31(4). doi:10.1111/ene.16191
BibTeX
@article{Pilotto2024,
author = {Pilotto, Andrea and Catania, Marcello and Mattioli, Irene and Zoppi, Nicola and Ceccardi, Giulia and Rao, Renata and Gipponi, Stefano and Magoni, Mauro and Gamba, Massimo and Padovani, Alessandro},
title = {Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination},
journal = {European Journal of Neurology},
year = {2024},
volume = {31},
number = {4},
doi = {10.1111/ene.16191}
}
EUVIMED